Imperial College London

ProfessorPaulCullinan

Faculty of MedicineNational Heart & Lung Institute

Prof of Occ and Env Respiratory Disease
 
 
 
//

Contact

 

+44 (0)20 7594 7990p.cullinan

 
 
//

Assistant

 

Miss Magda Wheatley +44 (0)20 7594 7990

 
//

Location

 

G47Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Summary

Paul Cullinan is Professor in Occupational and Environmental Respiratory Disease at the National Heart and Lung Institute and Honorary Consultant Physician in Respiratory Medicine at Royal Brompton Hospital, London.

Professor Cullinan's research interests centre around the distribution, aetiology and effects of respiratory disease with particular emphasis on their occupational and environmental relationships. The majority of his work with occupational disease has been in the area of workplace asthma, the commonest occupational respiratory disease in the UK, although recently he has extended his interests to COPD and asbestos-related conditions. As far as environmental work is concerned he has concentrated on early-life determinants of childhood asthma, in the UK and elsewhere, and on the effects of traffic exposures. Other interests include the epidemiology of interstitial lung diseases and cystic fibrosis and the respiratory effects of industrial or environmental disasters.

Within the Brompton Hospital he is part of the team which runs the busiest clinical service in the UK for the investigation and management of occupational and other environmental lung diseases.  Patients are referred from all parts of the UK for NHS treatment and care.

Professor Cullinan works as an advisor to a number of government bodies in his specialist field of occupational and environmental causes of lung disease.

Publications

Journals

Bloom CI, Drake TM, Docherty AB, et al., 2021, Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK, The Lancet Respiratory Medicine, Vol:9, ISSN:2213-2600, Pages:699-711

Walsh JA, Barker RE, Kon SSC, et al., 2021, Gait speed and adverse outcomes following hospitalised exacerbation of COPD, European Respiratory Journal, ISSN:0903-1936

Wiszniewska M, Dellis P, van Kampen V, et al., 2021, Characterization of Occupational Eosinophilic Bronchitis in a Multicenter Cohort of Subjects with Work-Related Asthma Symptoms, Journal of Allergy and Clinical Immunology-in Practice, Vol:9, ISSN:2213-2198, Pages:937-+

Bloom C, Tom D, Docherty A, et al., 2021, Risk of adverse outcomes in patients with underlying respiratory conditions hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: a national, multicentre prospective cohort, The Lancet Respiratory Medicine, ISSN:2213-2600

Coggon D, Croft P, Cullinan P, et al., 2020, Discussion on Covid age reply, Occupational Medicine-oxford, Vol:70, ISSN:0962-7480, Pages:687-688

More Publications